NCT04245774: Comparing the Effects of Levobupivacaine and Bupivacaine in Saddle Spinal Anesthesia |
|
|
| Completed | 4 | 60 | NA | Levobupivacaine (as Levobupivacaine Hydrochloride) 75 Mg/10 mL Solution for Injection Ampoule, 1 mL 0.75% isobaric levobupivacaine (Chirocaine® 75 mg/10mL ampoule Abbott/Turkey, Nycomed Pharma/Norway) plus 0.24 mL 50% Dextrose (dextrose 120 mg) (Eczacıbaşı/Turkey) and 0.26 mL distilled water., Bupivacaine/Dextrose, Marcaine® Spinal Heavy, 0.5%, 4 mL ampoule, AstraZeneca/England, Eczacıbaşı/Turkey, dextrose content 80 mg/mL. | Gazi University | Outpatients, General Surgery, Anorectal Disorder, Anesthesia, Drug Effect | 08/08 | 12/08 | | |
NCT04205344: Subarachnoid Bupivacaine in Obese Patients Undergoing Cesarean Delivery |
|
|
| Completed | 4 | 40 | RoW | Bupivacaine 5 mg, hyperbaric bupivacaine 1ml, bupivacaine/Dextrose 1ml, Bupivacaine 10 mg, hyperbaric bupivacaine 2 ml, bupivacaine/Dextrose 1 ml | Hospital Civil de Guadalajara | Anesthesia, Obstetrical | 06/17 | 05/18 | | |
NCT06060015: Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section |
|
|
| Recruiting | 4 | 106 | RoW | 5mg bupivacaine, hyperbaric bupivacaine 1ml, bupivacaine/Dextrose 1ml, 10mg bupivacaine, hyperbaric bupivacaine 2ml, bupivacaine/Dextrose 2ml | Hospital Civil de Guadalajara | Anesthesia, Obstetric Anesthesia Problems | 10/24 | 12/24 | | |
